NovaBridge Biosciences NBP
NASDAQ NBP
$1.37 -0.05 (-3.86%)
At close: Oct 21, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Other Operating Expenses (2024)

Updated

NovaBridge Biosciences' Other Operating Expenses was $129.87 million in FY2019, up 141.4% from $53.8 million in FY2018.

Analysis

NovaBridge Biosciences (NBP) Other Operating Expenses (2024) Analysis & Trends

  • Per Business Quant data, Other Operating Expenses in earlier years was $53.8 million in FY2018 (+121.9%) and $24.24 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 NovaBridge Biosciences 131.20 Mn -664.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 24.82 Mn
API Access

NovaBridge Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NBP&period=max&api_key=YOUR_API_KEY